Chung, Ki Young |
Prisma Health - Upstate
United States |
NCORP of the Carolinas (Greenville Health System NCORP) |
6UG1CA189972-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Chung, Ki Young |
Prisma Health - Upstate
United States |
NCORP of the Carolinas (Greenville Health System NCORP) |
6UG1CA189972-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Chung, Ki Young |
Prisma Health - Upstate
United States |
NCORP of the Carolinas (Greenville Health System NCORP) |
6UG1CA189972-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Chung, Ki Young |
Prisma Health - Upstate
United States |
NCORP of the Carolinas (Greenville Health System NCORP) |
6UG1CA189972-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Wang, Jing |
New York University School Of Medicine
United States |
Optimizing the use of ketamine to reduce chronic postsurgical pain |
5UH3CA261067-04 |
Brennan Streck, Ph.D., R.N., M.P.H. |
Largaespada, David Andrew |
University Of Minnesota
United States |
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention |
5UH3CA244687-05 |
Mark Steven Miller, Ph.D. |
Largaespada, David Andrew |
University Of Minnesota
United States |
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention |
5UH3CA244687-05 |
Mark Steven Miller, Ph.D. |
Largaespada, David Andrew |
University Of Minnesota
United States |
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention |
5UH3CA244687-05 |
Mark Steven Miller, Ph.D. |
Largaespada, David Andrew |
University Of Minnesota
United States |
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention |
5UH3CA244687-05 |
Mark Steven Miller, Ph.D. |
Frazier, Anne Lindsay |
Dana-Farber Cancer Inst
United States |
Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors |
5UH3CA240688-05 |
|